STOCK TITAN

[Form 4] Argan, Inc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Karen Sweeney, Director at Argan (AGX), reported multiple transactions involving Time-Based Restricted Stock Units (TRSUs):

  • On June 20, 2025, 1,300 TRSUs vested and were converted to common stock (adjusted for dividends, resulting in 1,315 shares) following a one-year vesting schedule from the June 2024 award
  • On June 17, 2025, received a new grant of 530 TRSUs, scheduled to vest fully on April 17, 2026

Following these transactions, Sweeney directly owns 1,705 shares of common stock and 530 unvested TRSUs. All transactions were executed at $0 exercise price, consistent with typical TRSU arrangements. These equity awards are part of the company's director compensation program.

Karen Sweeney, Direttrice di Argan (AGX), ha riportato diverse operazioni riguardanti le Time-Based Restricted Stock Units (TRSU):

  • Il 20 giugno 2025, 1.300 TRSU sono maturate e convertite in azioni ordinarie (aggiustate per dividendi, risultando in 1.315 azioni) secondo un piano di maturazione annuale a partire dall'assegnazione di giugno 2024
  • Il 17 giugno 2025, ha ricevuto una nuova concessione di 530 TRSU, con maturazione completa prevista per il 17 aprile 2026

Dopo queste operazioni, Sweeney possiede direttamente 1.705 azioni ordinarie e 530 TRSU non ancora maturate. Tutte le transazioni sono state eseguite con un prezzo di esercizio pari a 0$, in linea con le consuete condizioni delle TRSU. Questi premi azionari fanno parte del programma di compenso per i direttori della società.

Karen Sweeney, Directora en Argan (AGX), informó varias transacciones relacionadas con Unidades Restringidas de Acciones Basadas en Tiempo (TRSUs):

  • El 20 de junio de 2025, 1,300 TRSUs se consolidaron y convirtieron en acciones comunes (ajustadas por dividendos, resultando en 1,315 acciones) siguiendo un calendario de consolidación de un año desde la concesión de junio de 2024
  • El 17 de junio de 2025, recibió una nueva asignación de 530 TRSUs, programadas para consolidarse completamente el 17 de abril de 2026

Tras estas transacciones, Sweeney posee directamente 1,705 acciones comunes y 530 TRSUs no consolidadas. Todas las operaciones se realizaron con un precio de ejercicio de $0, conforme a los términos habituales de las TRSUs. Estas concesiones de acciones forman parte del programa de compensación para directores de la empresa.

카렌 스위니, Argan(AGX) 이사는 시간 기반 제한 주식 단위(TRSU)와 관련된 여러 거래를 보고했습니다:

  • 2025년 6월 20일, 1,300 TRSU가 권리 취득되어 보통주로 전환되었으며(배당금 조정 후 1,315주로 조정), 2024년 6월 부여일부터 1년간의 권리 취득 일정에 따른 것입니다
  • 2025년 6월 17일, 530 TRSU의 신규 부여를 받았으며, 2026년 4월 17일에 완전 권리 취득 예정입니다

이 거래들 이후 스위니는 직접적으로 1,705주의 보통주와 530주의 미권리 취득 TRSU를 보유하고 있습니다. 모든 거래는 $0의 행사가격으로 실행되었으며, 이는 일반적인 TRSU 조건과 일치합니다. 이 주식 보상은 회사의 이사 보상 프로그램의 일부입니다.

Karen Sweeney, directrice chez Argan (AGX), a déclaré plusieurs transactions impliquant des unités d'actions restreintes basées sur le temps (TRSUs) :

  • Le 20 juin 2025, 1 300 TRSUs ont été acquises et converties en actions ordinaires (ajustées pour dividendes, soit 1 315 actions) selon un calendrier d'acquisition d'un an depuis l'attribution de juin 2024
  • Le 17 juin 2025, elle a reçu une nouvelle attribution de 530 TRSUs, devant être entièrement acquises le 17 avril 2026

À la suite de ces transactions, Sweeney possède directement 1 705 actions ordinaires et 530 TRSUs non acquises. Toutes les transactions ont été réalisées à un prix d'exercice de 0 $, conformément aux modalités habituelles des TRSUs. Ces attributions d'actions font partie du programme de rémunération des administrateurs de la société.

Karen Sweeney, Direktorin bei Argan (AGX), meldete mehrere Transaktionen im Zusammenhang mit zeitbasierten Restricted Stock Units (TRSUs):

  • Am 20. Juni 2025 wurden 1.300 TRSUs fällig und in Stammaktien umgewandelt (dividendenbereinigt auf 1.315 Aktien), gemäß einem einjährigen Vesting-Zeitplan ab der Zuteilung im Juni 2024
  • Am 17. Juni 2025 erhielt sie eine neue Zuteilung von 530 TRSUs, die vollständig am 17. April 2026 vesten sollen

Nach diesen Transaktionen besitzt Sweeney direkt 1.705 Stammaktien und 530 unverfallene TRSUs. Alle Transaktionen erfolgten zu einem Ausübungspreis von 0 $, was den üblichen TRSU-Bedingungen entspricht. Diese Aktienzuteilungen sind Teil des Vergütungsprogramms für Direktoren des Unternehmens.

Positive
  • None.
Negative
  • None.

Karen Sweeney, Direttrice di Argan (AGX), ha riportato diverse operazioni riguardanti le Time-Based Restricted Stock Units (TRSU):

  • Il 20 giugno 2025, 1.300 TRSU sono maturate e convertite in azioni ordinarie (aggiustate per dividendi, risultando in 1.315 azioni) secondo un piano di maturazione annuale a partire dall'assegnazione di giugno 2024
  • Il 17 giugno 2025, ha ricevuto una nuova concessione di 530 TRSU, con maturazione completa prevista per il 17 aprile 2026

Dopo queste operazioni, Sweeney possiede direttamente 1.705 azioni ordinarie e 530 TRSU non ancora maturate. Tutte le transazioni sono state eseguite con un prezzo di esercizio pari a 0$, in linea con le consuete condizioni delle TRSU. Questi premi azionari fanno parte del programma di compenso per i direttori della società.

Karen Sweeney, Directora en Argan (AGX), informó varias transacciones relacionadas con Unidades Restringidas de Acciones Basadas en Tiempo (TRSUs):

  • El 20 de junio de 2025, 1,300 TRSUs se consolidaron y convirtieron en acciones comunes (ajustadas por dividendos, resultando en 1,315 acciones) siguiendo un calendario de consolidación de un año desde la concesión de junio de 2024
  • El 17 de junio de 2025, recibió una nueva asignación de 530 TRSUs, programadas para consolidarse completamente el 17 de abril de 2026

Tras estas transacciones, Sweeney posee directamente 1,705 acciones comunes y 530 TRSUs no consolidadas. Todas las operaciones se realizaron con un precio de ejercicio de $0, conforme a los términos habituales de las TRSUs. Estas concesiones de acciones forman parte del programa de compensación para directores de la empresa.

카렌 스위니, Argan(AGX) 이사는 시간 기반 제한 주식 단위(TRSU)와 관련된 여러 거래를 보고했습니다:

  • 2025년 6월 20일, 1,300 TRSU가 권리 취득되어 보통주로 전환되었으며(배당금 조정 후 1,315주로 조정), 2024년 6월 부여일부터 1년간의 권리 취득 일정에 따른 것입니다
  • 2025년 6월 17일, 530 TRSU의 신규 부여를 받았으며, 2026년 4월 17일에 완전 권리 취득 예정입니다

이 거래들 이후 스위니는 직접적으로 1,705주의 보통주와 530주의 미권리 취득 TRSU를 보유하고 있습니다. 모든 거래는 $0의 행사가격으로 실행되었으며, 이는 일반적인 TRSU 조건과 일치합니다. 이 주식 보상은 회사의 이사 보상 프로그램의 일부입니다.

Karen Sweeney, directrice chez Argan (AGX), a déclaré plusieurs transactions impliquant des unités d'actions restreintes basées sur le temps (TRSUs) :

  • Le 20 juin 2025, 1 300 TRSUs ont été acquises et converties en actions ordinaires (ajustées pour dividendes, soit 1 315 actions) selon un calendrier d'acquisition d'un an depuis l'attribution de juin 2024
  • Le 17 juin 2025, elle a reçu une nouvelle attribution de 530 TRSUs, devant être entièrement acquises le 17 avril 2026

À la suite de ces transactions, Sweeney possède directement 1 705 actions ordinaires et 530 TRSUs non acquises. Toutes les transactions ont été réalisées à un prix d'exercice de 0 $, conformément aux modalités habituelles des TRSUs. Ces attributions d'actions font partie du programme de rémunération des administrateurs de la société.

Karen Sweeney, Direktorin bei Argan (AGX), meldete mehrere Transaktionen im Zusammenhang mit zeitbasierten Restricted Stock Units (TRSUs):

  • Am 20. Juni 2025 wurden 1.300 TRSUs fällig und in Stammaktien umgewandelt (dividendenbereinigt auf 1.315 Aktien), gemäß einem einjährigen Vesting-Zeitplan ab der Zuteilung im Juni 2024
  • Am 17. Juni 2025 erhielt sie eine neue Zuteilung von 530 TRSUs, die vollständig am 17. April 2026 vesten sollen

Nach diesen Transaktionen besitzt Sweeney direkt 1.705 Stammaktien und 530 unverfallene TRSUs. Alle Transaktionen erfolgten zu einem Ausübungspreis von 0 $, was den üblichen TRSU-Bedingungen entspricht. Diese Aktienzuteilungen sind Teil des Vergütungsprogramms für Direktoren des Unternehmens.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sweeney Karen

(Last) (First) (Middle)
22550 CALVERTON ROAD

(Street)
SHAKER HEIGHTS OH 44122

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 06/20/2025 M 1,315(1) A $0 1,705 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Time-Based Restricted Stock Unit $0 06/17/2025 A 530 (2) (2) Common Stock 530 $0 1,830 D
Time-Based Restricted Stock Unit $0 06/20/2025 M 1,300 (1) (1) Common Stock 1,300 $0 530 D
Explanation of Responses:
1. Pursuant to the one-year vesting schedule of the Time-Based Restricted Stock Unit ("TRSU") awarded to the Reporting Person on June 20, 2024, 1,300 shares of Common Stock became issuable to the Reporting Person on June 20, 2025 and is adjusted for dividends.
2. On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on April 17, 2026.
/s/ Karen A. Sweeney 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many AGX restricted stock units (RSUs) did Karen Sweeney receive on June 17, 2025?

Karen Sweeney received 530 Time-Based Restricted Stock Units (TRSUs) of AGX on June 17, 2025. These TRSUs will fully vest on April 17, 2026.

When did Karen Sweeney's 2024 AGX restricted stock units vest?

Karen Sweeney's TRSUs from June 20, 2024 vested on June 20, 2025, resulting in 1,300 shares of AGX common stock being issued (adjusted for dividends).

How many AGX shares does Karen Sweeney own directly after the June 2025 transactions?

Following the reported transactions, Karen Sweeney directly owns 1,705 shares of AGX common stock and 530 unvested Time-Based Restricted Stock Units.

What is Karen Sweeney's role at AGX according to the Form 4?

According to the Form 4 filing, Karen Sweeney serves as a Director of Argan, Inc. (AGX), as indicated by the 'X' marked in the Director box under the Relationship of Reporting Person(s) to Issuer section.
Argan Inc

NYSE:AGX

AGX Rankings

AGX Latest News

AGX Latest SEC Filings

AGX Stock Data

2.84B
13.06M
7.02%
89.4%
4.4%
Engineering & Construction
Construction - Special Trade Contractors
Link
United States
ARLINGTON